- Home
- ELVR vs IOVA Comparison
ELVR vs IOVA Comparison
Compare ELVR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVR | IOVA |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 890.2M | 881.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVR | IOVA |
|---|---|---|
| Price | $65.45 | $2.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $10.45 |
| AVG Volume (30 Days) | 82.4K | ★ 12.7M |
| Earning Date | 03-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $146,440,045.00 | ★ $250,425,000.00 |
| Revenue This Year | $22.93 | $60.71 |
| Revenue Next Year | $7.27 | $59.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 11.20 | ★ 175.62 |
| 52 Week Low | $15.55 | $1.64 |
| 52 Week High | $69.99 | $6.50 |
Technical Indicators
Market Signals| Indicator | ELVR | IOVA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.89 |
| Support Level | N/A | $2.21 |
| Resistance Level | N/A | $2.80 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 49.19 |
Price Performance
Historical ComparisonAbout ELVR Sayona Mining Limited American Depository Shares
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.